Results 21 to 30 of about 329,096 (211)
Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
Ashwathy S Mathew,1 Laura A Dawson2,3 1Department of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India; 2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; 3Department of Radiation Oncology ...
Mathew AS, Dawson LA
doaj +1 more source
Bibliometric analysis of stereotactic ablative radiotherapy for oligometastases. [PDF]
Background Oligometastases, an intermediate stage of metastatic cancer, are increasingly managed with Stereotactic Ablative Radiotherapy (SABR), a highly precise local therapy representing a pivotal paradigm shift for improving patient outcomes.
Di Y, Song Z, Wang Y, Meng L, Li J.
europepmc +4 more sources
Stereotactic ablative body radiotherapy (SABR) is routinely used for the management of oligometastatic disease. Increasingly, there is overlap of targets or organs at risk with previous radiotherapy fields.
Elena Moreno-Olmedo +20 more
doaj +2 more sources
Prostate cancer - what about oligometastatic disease and stereotactic ablative radiotherapy? - a narrative review [PDF]
Oligometastatic prostate cancer (OMPC) encompasses a heterogenous group of clinical entities defined by the timing of the development of metastases. These include de novo oligometastatic, oligorecurrent and oligoprogressive prostate cancer (PrCa).
Helen Saxby +8 more
core +3 more sources
Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch
This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, in comparison with the more widely adapted multi-fraction SABR regimens ...
Guckenberger, M. +21 more
core +2 more sources
Stereotactic ablative radiotherapy for oligometastatic prostate cancer
The present study assessed clinical outcomes of stereotactic body radiotherapy (SBRT) in oligometastatic prostate cancer patients.Between 2017 and 2020, 37 lesions (12 osseous and 25 nodal targets) detected with conventional and/or functional imaging, were treated in 29 patients (pts), in different clinical settings: de novo oligometastatic (2 pts ...
Gallizia, Elena +7 more
openaire +3 more sources
This paper aims to provide guidance and a framework for commissioning tests and tolerances for the ExacTrac Dynamic image-guided and surface-guided radiotherapy (SGRT) system. ExacTrac Dynamic includes a stereoscopic X-ray system, a structured light projector, stereoscopic cameras, thermal camera for SGRT, and ...
Ramachandran, Prabhakar +4 more
openaire +5 more sources
Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma
Clinical outcomes after stereotactic ablative radiotherapy in locally advanced ...
Esben Schjødt Worm (11636163) +6 more
core +1 more source
Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver [PDF]
Liver metastasis in solid tumors, including colorectal cancer, is the most frequent and lethal complication. The development of systemic therapy has led to prolonged survival. However, in selected patients with a finite number of discrete lesions in liver, defined as oligometastatic state, additional local therapies such as surgical resection ...
Kim, Myungsoo +3 more
openaire +2 more sources
It is well known that radiotherapy provides successful pain relief in bone metastases. Advancements in imaging and radiotherapy delivery technology have enabled safe delivery of higher dose radiotherapy, which will produce more durable tumor control ...
HENRY KODRAT, SOEHARTATI GONDHOWIARDJO
doaj +1 more source

